A detailed history of Franklin Resources Inc transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 4,642,460 shares of ARQT stock, worth $43.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,642,460
Previous 4,655,544 0.28%
Holding current value
$43.2 Million
Previous $15 Million 205.95%
% of portfolio
0.02%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.25 - $11.77 $42,523 - $153,998
-13,084 Reduced 0.28%
4,642,460 $46 Million
Q4 2023

Feb 09, 2024

BUY
$1.84 - $4.82 $6.19 Million - $16.2 Million
3,363,191 Added 260.24%
4,655,544 $15 Million
Q3 2023

Nov 13, 2023

SELL
$5.31 - $10.98 $1.91 Million - $3.95 Million
-360,183 Reduced 21.8%
1,292,353 $6.86 Million
Q2 2023

Aug 11, 2023

BUY
$7.51 - $15.0 $444,336 - $887,490
59,166 Added 3.71%
1,652,536 $15.7 Million
Q1 2023

May 12, 2023

BUY
$10.23 - $17.14 $8.14 Million - $13.6 Million
795,634 Added 99.74%
1,593,370 $17.5 Million
Q4 2022

Feb 10, 2023

SELL
$13.96 - $20.4 $17,589 - $25,704
-1,260 Reduced 0.16%
797,736 $11.8 Million
Q3 2022

Nov 14, 2022

BUY
$17.85 - $26.95 $91,035 - $137,445
5,100 Added 0.64%
798,996 $15.3 Million
Q2 2022

Aug 11, 2022

BUY
$16.33 - $22.2 $2.19 Million - $2.98 Million
134,060 Added 20.32%
793,896 $16.9 Million
Q1 2022

May 13, 2022

BUY
$14.38 - $22.79 $634,028 - $1 Million
44,091 Added 7.16%
659,836 $12.7 Million
Q4 2021

Feb 11, 2022

BUY
$14.98 - $25.5 $607,244 - $1.03 Million
40,537 Added 7.05%
615,745 $12.8 Million
Q3 2021

Nov 12, 2021

SELL
$19.28 - $27.1 $10,025 - $14,092
-520 Reduced 0.09%
575,208 $13.7 Million
Q2 2021

Aug 13, 2021

SELL
$24.42 - $34.75 $1.89 Million - $2.69 Million
-77,280 Reduced 11.83%
575,728 $15.7 Million
Q1 2021

May 13, 2021

BUY
$24.47 - $36.98 $16 Million - $24.1 Million
653,008 New
653,008 $18.9 Million

Others Institutions Holding ARQT

About Arcutis Biotherapeutics, Inc.


  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $560M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.